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Abstract
OBJECTIVE: This is a review of the effects of Chi-
nese herbal medicine (CHM) used alone to treat
lumbar disc herniation (LDH).
METHORDS: A literature search of the following
electronic databases from their inception to Febru-
ary 2013 was conducted: Chinese Biomedical data-
bases, Chinese National Knowledge Infrastructure,
Wanfang Database, China Science and Technology
Journal Database, Cochrane Library, Web of Sci-
ence, MEDLINE, and EMBASE. Randomized con-
trolled trials where CHM had been used to treat
LDH were selected. Data extraction, quality assess-
ment, and data analysis were carried out by two in-
dependent reviewers.
RESULTS: Of the 2415 studies identified, eight with
complete data on 1146 patients were selected. The
methodological quality was poor in all trials. Five
studies reported that CHM was better than Western
Medicine [OR=2.81, 95% CI (1.27, 6.18); OR=3.34,
95% CI (1.92, 5.79); OR=2.22, 95% CI (1.08, 4.57); OR=
6.67, 95% CI (1.34, 33.28); and OR=1.94, 95% CI
(1.23, 3.06)]. Two studies reported that the clinical
outcome was better in CHM groups than in physio-
therapy and placebo groups, [OR=3.02, 95% CI
(1.08, 8.46); and OR=2.67, 95% CI (1.26, 5.64), re-
spectively], whereas one study reported no differ-
ence between CHM and physiotherapy groups.
One study reported that CHM resulted in higher
Japanese Orthopedic Association scores [MD=7.78,
95% CI (6.67, 8.89)] than in a control group and an-
other that participants treated with CHM had lower
Visual Analogue Scale scores [MD=﹣ 0.72, 95% CI
(﹣ 0.86, ﹣ 0.58)] than those in a control group.
Three studies reported that the adverse effects of
CHM and Western Medicine did not differ signifi-
cantly [OR=0.10, 95% CI (0.01, 1.85); OR=0.19, 95%
CI (0.01, 4.07); and OR=0.07, 95% CI (0.00, 1.32)].
CONCLUSION: CHM may be more effective than
other interventions for LDH; however, methodologi-
cal weaknesses in the studies assessed in this re-
view prevent a definitive conclusion. More
high-quality large-scale studies are required to clar-
ify this matter.
© 2013 JTCM. All rights reserved.
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INTRODUCTION
Displacement of the lumbar disc beyond a damaged an-
nulus fibrosus is defined as lumbar disc herniation
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(LDH).1 Its prevalence is about 1%-3% in European
countries. The highest incidence is among people aged
30-50 years and the ratio of male to female is 2∶1.2
The commonest symptoms caused by LDH are lower
back pain (LBP) and sciatica (a specific subgroup of
LBP).3 It imposes an economic burden on patients be-
cause of their frequent absences from work.4
Some conventional treatments for LBP, including vari-
ous surgical treatments, non-steroidal anti-inflammato-
ry drugs (NSAIDs), neurotrophics, and dehydrating
drugs, have positive effects. However, some adverse ef-
fects of Western Medical treatments are unavoidable.
The risk of gastrointestinal bleeding with NSAIDs is
high in elderly patients.5
In the practice of Traditional Chinese Medicine
(TCM), Chinese herbal medicine (CHM) has long
been used to treat LDH. In terms of TCM theory,
LDH is known as "Yao Bi" and is usually caused by
blood stasis and Qi stagnation, cold-dampness, or defi-
ciencies in liver and kidney function.
Recently, the effectiveness of CHM for treating LDH
has been reported widely. However, many of these stud-
ies did not evaluate the effects of CHM used alone.
The present systematic review aimed to use evidence
from published randomized clinical trials to evaluate
the efficacy of CHM used alone to treat LDH.
METHODS
Search strategy
Domestic databases, including the Chinese Biomedical
databases, Chinese National Knowledge Infrastructure,
Wanfang database, and China Science and Technology
Journal database (CSTJ), were searched. The overseas
databases searched included the Cochrane Library,
Web of Science, MEDLINE, and EMBASE. All data-
bases were searched from inception up to February
2013. Papers presented at the International Congress
of the Chinese Orthopedic Association from its incep-
tion up to 2012 were also manually searched. Unpub-
lished studies were identified using Google. The terms
used for searching were as follows: (a) low back pain.
(b) lumbar disc degeneration; (c) spinal diseases; (d)
lumbar disc herniation; (e) 1 or 2 or 3 or 4; (f ) alterna-
tive medicine; (g) herb; (h) Chinese herbal medicine;
(i) nonprescription drug; (j) botanical; (k) 6 or 7 or 8
or 9 or 10; (l) controlled clinical trial; (m) randomized
controlled trial; (n) randomized; (o) placebo; (p) ran-
domly; (q) trial; (r) 12 or 13 or 14 or 15 or 16 or 17;
(s) 5 and 11 and 18.
Inclusion criteria
Types of study: all randomized controlled trials related
to LDH were included, regardless of language.
Types of participant: adult patients with a definite diag-
nosis of LDH. Patients with other diseases, such as
trauma, tumor, fracture, infection, muscle strain, or spi-
nal deformity, were excluded.
Types of intervention: the treatment groups included
only used CHM/formulae either internally or external-
ly or both. The control groups used other treatments
such as placebos and Western Medicine-type medica-
tions. Studies in which CHM was used in the control
groups were excluded, as were those that used non-Chi-
nese herbal medicines.
Types of outcome measure: outcome measures were
clinical efficacy, adverse effects, Japanese Orthopedic
Association (JOA) scores, and Visual Analogue Scale
(VAS) scores.
Data extraction and assessment
All articles were identified by the specific search strate-
gies described above. Two reviewers (Luo and Huang)
assessed the articles independently. Any disagreements
were resolved by a third reviewer (Hu). Similarly, the
data were independently extracted by two researchers
(Luo and Huang) according to the defined criteria and
differences of opinion resolved by the third reviewer
(Hu). Figure 1 is a flow chart depicting the selection
process and the reasons for exclusion.
The risk of bias was evaluated using the Cochrane Col-
laboration's risk of bias criteria, which are as follows:
(a) random sequence generation; (b) allocation conceal-
ment; (c) blinding of participants and personnel; (d)
blinding of outcome assessment; (e) incomplete out-
come data; (f ) selective reporting; and (g) other bias-
es.6 Two of the authors (Luo and Huang) indepen-
dently evaluated the quality of the studies and con-
sulted with the other authors when their viewpoints
differed.
Data analysis
The program Revman 5.1 (Cochrane Collaboration,
Oxford, UK) was used to compare the outcomes of the
treatment groups with the control groups for all statisti-
cal analyses. Odds ratio (OR) were used to compare di-
chotomous data and mean differences (MD) to com-
pare continuous variables and 95% confidence inter-
vals (CI) calculated for them. Meta-analyses were per-
formed where the interventions were comparable and
the heterogeneity low. Heterogeneity was assessed
based on the χ2 test. A random effects model was used
for meta-analysis where there was significant heteroge-
neity (P<0.10) and a fixed effects model where there
was not significant heterogeneity (P≥0.10).
RESULTS
Study selection and characteristics
In total, 2415 studies were retrieved using the search
terms. Of these studies, 1351 were in English and
1064 in Chinese. One hundred and four studies were
excluded because of duplication and a further 2238 af-
ter reading their titles and abstracts. An additional 453
studies were excluded because they were not relevant to
LDH, 726 studies because they were not relevant to
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CHM, 188 studies because they were not clinical trials,
845 studies because multiple inventions had been per-
formed in both control and treatment groups, and 26
studies because they were reviews. The full texts of the
remaining 73 studies were obtained for further evalua-
tion, after which 65 of them were excluded based on
our evaluation of the detailed data: 36 because CHMs
were used in the control group, 17 because there were
multiple inventions in the treatment groups (not noted
in the abstracts), and 12 because they were not ran-
domized controlled trials (Figure 1). Finally, eight stud-
ies remained, all of which had been published in Chi-
nese journals and performed in China.7-14 These eight
trials involved 1146 patients in total (Table 1).
Study quality
Only two of the studies7,14 used an appropriate se-
quence generation method. None of the studies report-
2415 records identified through
database searching
104 records removed due to
duplicates
2311 records screened
2238 records excluded
Not relevant to LDH (n=453)
Not relevant to CHM (n=726)
Not relevant to clinical trials
(n=188)
Other inventions in control and
treatment groups (n=845)
Review (n=26)
73 full-text articles assessed for
eligibility
65 of full-text articles excluded
CHM in control groups (n=36)
Multiple inventions in treatment
groups (abstract not shown) (n=17)
Not RCTs (n=12)
8 studies included
Figure 1 Flow diagram showing selection procedure
LDH: lumbar disc herniation; CHM: Chinese herbal medicine; RCTs: randomized controlled trials.
Author
Li BJ
20097
Ye KX
20068
Diao JH
20089
Li CJ
200910
Chen FH
201111
Ma YX
201112
Zhao CW
201013
Wang LX
201214
Case
124
60
108
240
120
68
116
310
Inclusion criteria
Criteria of Diagnostic and
Therapeutic Effect of
Chinese Medicine for Disease
Manipulations of Diagnostic
and Therapeutic Effect of
Chinese Medicine
CT and MRI
Practical Orthopaedics
Criteria of Diagnostic and
Therapeutic Effect of
Chinese Medicine for Disease
Criteria of Diagnostic and
Therapeutic Effect of
Chinese Medicine for Disease
Criteria of Diagnostic and
Therapeutic Effect of
Chinese Medicine for Disease
CT and MRI
Age
(years)
25-50
18-70
Control:
23-56
Treatment:
24-55
Control:
34.4
Treatment:
33.3
20-70
30-60
21-65
26-70
Treatment
Duhuojishen
decoction
Jingyaotong
decoction
Yaotonghuoxue
capsule
Jingyaotong
capsule
Biechongchubi
caspule
Duhuojishen
decoction
CHM hot
compress
Duhuojishen
decoction
Control
Diclofenacsodium
Lumbar traction
Meloxicam
Ibuprofen
Placebo
Diclofenac sodium
Electromagnet
wave
Diclofenac sodium
Course
(days)
20
28
14
30
15
21
20
21
Outcome
CR
AE
CR
CR
CR
CR
JOA
CR
AE
CR
CR
AE
VAS
Notes: CHM: Chinese herbal medicine; CR: curative rate; AE: adverse effects; JOA: Japanese orthopedic association scores; VAS: visual
analogue scale.
Table 1 Characteristics of assessed studies
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Low risk of bias Unclear risk of bias High risk of bias
Random sequence generation (selection bias)
Allocation concealment (selection bias)
Blinding of participants and personnel (performance bias)
Blinding of outcome assessment (detection bias)
Incomplete outcome data (attrition bias)
Selective reporting (reporting bias)
Other bias
0% 25% 50% 75% 100%
Figure 3 Bar graph showing risk of bias
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ed allocation concealment or blinding and none report-
ed complete outcomes (Figures 2 and 3).
Assessment of outcomes
The rate of cure was used as an indicator of clinical effi-
cacy in all of the assessed studies.7-14 One study8 used
the Manipulations of Diagnostic and Therapeutic Ef-
fect of Chinese Medicine, six used the Criteria of Diag-
nostic and Therapeutic Effect of Chinese Medicine for
Disease, and the remaining one14 used criteria devised
by the author. Based on these criteria, outcomes were
allocated to one of four levels: cure, significantly effec-
tive, effective, and ineffective. Rate of cure was to be
calculated from the number of cured cases (first level);
however, this meta-analysis was abandoned because the
assessed studies were too clinically diverse, with vari-
able types of intervention and different treatment
courses.
Curative rate
Five studies7,9,10,12,14 compared CHM with Western Med-
icine, two compared CHM with physiotherapy, and
one compared CHM with placebo. In seven studies,7,9-14
the CHM groups had a higher rate of cure than the
control groups. One study reported no difference be-
tween CHM and physiotherapy (Figure 4).
JOA scores
In the one study11 that used JOA scores, these scores
were higher in the CHM group than in the control
group [MD=7.78, 95% CI (6.67, 8.89)].
VAS scores
In the one study14 that used VAS scores, these scores
were lower in the CHM group than in the control
group [MD=﹣0.72, 95% CI (﹣0.86,﹣0.58)].
Adverse effects
Three studies7,12,14 reported adverse effects, specifically
stomach discomfort. All three studies reported no dif-
ferences between the CHM and control groups in ad-
verse effects (Figure 5).
Publication bias
Funnel plots produced to assess publication bias
showed an asymmetrical distribution (Figure 6). Thus,
there is a publication bias in our review.
DISCUSSION
Our review shows that CHM therapy alone produces a
better clinical outcome than other therapies in patients
with LDH. There was no difference between CHM
and Western Medicine in terms of the risk of adverse
effects. However, methodological limitations compro-
mise the reliability of these conclusions.
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Figure 2 Summary of risk of bias
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Reasons for the possible effectiveness of CHM
Experimental studies have shown that CHMs may
help to prevent degeneration of the lumbar disc and
that they have analgesic effects. The mechanisms that
underlie the effects of CHM in LDH remain un-
known; however, CHM are known to have significant
anti-inflammatory effects. In animal models, Yaotu-
itong capsules15 reportedly significantly reduce prosta-
glandin E2 and 5-hydroxytryptamine concentrations
in injured nerve roots. CHM16 can increase type II col-
lagen concentrations and decrease expression of metal-
loproteinase 3, metalloproteinase 13, and interleu-
kin-1β in degenerated discs. These studies may explain
why CHM both relieves the symptoms of LDH and al-
so prevents disc degeneration.
According to TCM theory, development of LDH is at-
tributable to deficiencies of the kidney, injuries, and in-
vasion by exogenous pathogenic wind, cold, and damp-
ness. Because invasion of exogenous adverse elements
and injury block the meridian, patients experience
pain. Drugs that improve blood circulation, such as
Ruxiang (Olibanum), Moyao (Myrrh), Danggui (Radix
Angelicae Sinensis), and Chuanxiong (Rhizoma Chuanx-
iong), have beneficial effects. In addition, Qi-tonifying
drugs, such as Duzhong (Cortex Eucommiae), Niuxi
(Radix Achyranthis Bidentatae), Huangqi (Radix Astrag-
ali Mongolici) and Wujiapi (Cortex Acanthopanacis Radi-
cis), which improve kidney function or strengthen
bones, are also effective.
Limitations of the evidence
This review has some drawbacks because of the follow-
ing limitations in the studies assessed. (a) All the stud-
ies were written in Chinese and published in Chinese
journals. Positive results of clinical research related to
CHM are more likely to be published in China. Thus,
a publication bias was inevitable and this was indeed
present according to our funnel plots. (b) Only two
studies described an appropriate random sequence gen-
eration procedure using a random number table. Thus,
these studies had a high risk of selection bias. (c) Perfor-
mance bias and detection bias were not considered in
these studies. Blinding is very important for protecting
against bias and ensuring that valid results are ob-
tained. Regrettably, all eight assessed studies were un-
CHM vsWM CHM vs physiotherapy
CHM vs placebo
0.0
0.2
0.4
0.6
0.8
1.0 OR0.05 0.2 1 5 20
SE (log [OR]
Figure 6 Funnel plot
WM:Western Medicine; CHM: Chinese herbal medicine.
Luo Y et al. / Systematic Review
Figure 4 Comparison of rates of cure
WM:Western Medicine; CHM: Chinese herbal medicine.
Figure 5 Complications
WM:Western Medicine; CHM: Chinese herbal medicine.
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clear about blinding of participants and personnel and
blinding of outcome assessments. Thus, the likelihoods
of performance biases and detection biases were high.
(d) None of the studies mentioned attrition or with-
drawal rates. Intention-to-treat analyses were not per-
formed in any of the studies assessed. Thus, it is possi-
ble that there was a high risk of attrition bias. Overall,
our findings therefore provide limited evidence on this
topic.
How does this review differ from other reviews?
Several systematic reviews of CHM have reported simi-
lar findings on this topic. A systematic review17 of a
Duhuojishen decoction included various studies; how-
ever, in these studies, the treatment groups received
CHM combined with other therapies. With the aim of
evaluating the efficacy of CHM alone in the treatment
of LDH, we only included studies in which the treat-
ment group received CHM alone. Although their
methodological quality was low, the studies we identi-
fied did provide some information that is relevant to
clinical practice.
Studies of LBP treatment with herbal medicines per-
formed outside China have been included in previous
systematic reviews.18,19 However, the herbal medicines
used in those studies are not the same as those used in
CHM and those studies were only included to guide
basic research and clinical treatments. We excluded
clinical studies of herbal medicines that were not guid-
ed by TCM theory.
Recommendations for future clinical research and
practice
Future studies should describe their randomization pro-
cedures in greater detail, perform allocation conceal-
ment as far as possible, apply a blinding method dur-
ing the assessment procedure, and report inten-
tion-to-treat analyses. There is a need for large clinical
trials to test the efficacy of CHM. We recommend that
CHM should be combined with other LDH therapies,
such as Western Medicine and physiotherapy.
CONCLUSION
According to our review, CHM had beneficial effects
on LDH. However, we did identify some methodologi-
cal defects that weakened the reliability of our conclu-
sions. In spite of this limitation, our findings might in-
form future clinical practice and research.
REFERENCES
1 Hahne AJ, Ford JJ, McMeeken JM. Conservative manage-
ment of lumbar disc herniation with associated radiculopa-
thy a systematic review. Spine 2010; 35(11): E488-E504.
2 Jordan J, Konstantinou K, O'Dowd J. Herniated lumbar
disc. Clinical evidence 2009; 2009: 1118.
3 Shiri R, Karppinen J, Leino-Arjas P, et al. Cardiovascular
and lifestyle risk factors in lumbar radicular pain or clini-
cally defined sciatica: a systematic review. Eur Spine J
2007; 16(12): 2043-2054.
4 Wahlstrom J, Burstrom L, Nilsson T, Jarvholm B. Risk
factors for hospitalization due to lumbar disc disease.
Spine 2012; 37(15): 1334-1339.
5 Sostres C, Lanas A. Gastrointestinal effects of aspirin. Nat
Rev Gastroenterol Hepatol 2011; 8(7): 385-394.
6 Higgins JPT, Green S. Cochrane handbook for systematic
reviews of interventions version 5.1.0 updated March
2011. The Cochrane Library, 2011. Cited 2013-02. Avail-
able from: URL: http://www.cochrane-handbook.org.
7 Li BJ, He WR. Observations on treatment of 64 patients
suffering from lumbar intervertebral disc herniation with
Duhuojisheng decoction. Xian Dai Zhong Xi Yi Jie He Za
Zhi 2009; 18(27): 3319-3320.
8 Ye KX, Wang Y, Liu YD. Clinical observation of 32 cases
of lumbar disc herniation with Jing Yao TongⅠFormula.
Shi Yong Zhong Yi Nei Ke Za Zhi 2006; 20(3): 322-323.
9 Diao JH, Zhang JH, Lv ZM. Clinical exprience of Yao-
tonghuoxue Capsule treatment of lumbar disc herniation.
Zhong Guo Zhong Yi Ji Zhen Za Zhi 2008; 17(7):
1004-1005.
10 Li CJ, Huang M, Zhang Z, Jia HR, Huang BH. One hun-
dred and fifty cases of lumbar disc herniation with Jing
Yao Tong Formula. Shanxi Zhong Yi Za Zhi 2009; 30
(10): 1346-1347.
11 Chen FH, Chen ZJ, Xu YH. Clinical observation of
Biechongchubi capsule treatment of Qi stagnation and
blood stasis low back pain. Guiyang Zhong Yi Xue Yuan
Xue Bao 2011; 3(9): 54-56.
12 Ma YX, Zhao YH, Huang MH, et al. Duhuojisheng de-
coction treatment for lumbar disc herniation in 34 pa-
tients. Zhong Guo Shi Yong Fang Ji Xue 2011; 17(15):
241-243.
13 Zhao CW, Li JX, Leng XY, et al. Effects of externally ap-
plied Chinese herb medcine treatment of lumbar disc her-
niation. Zhong Yi Zheng Gu 2010; 22(12): 21-22.
14 Wang LX. Observations on treatment of patients suffer-
ing from lumbar intervertebral disc herniation with
Duhuojisheng Decoction. Quan Ke Yi Xue Yu Lin Ch-
uang Jiao Yu 2012; 10(6): 685-687.
15 Xing QC, Huang ZJ, Zhang JF. Anti-inflammatory and
analgesic effects of Yaotuitong capsules in experimental
rats with chemically induced radicular neuritis. J Tradit
Chin Med 2012; 32(3): 437-441.
16 Liang QQ, Xi ZJ, Bian Q, et al. Herb formula "Fufangq-
ishe-Pill" prevents upright posture-induced intervertebral
disc degeneration at the lumbar in rats. J Pharmacol Sci
2010; 113(1): 23-31.
17 YX Ma, JY Cui, MH Huang, K Meng, YH Zhao. Effects
of Duhuojisheng Tang and combined therapies on pro-
lapse of lumbar intervertebral disc: a systematic review of
randomized control trails. J Tradit Chin Med 2013; 33(2):
145-155.
18 Gagnier JJ, Van Tulder MW, Berman B, Bombardier C.
Herbal medicine for low back pain: a Cochrane review.
Spine 2007; 32(1): 82-89.
19 Rubinstein SM, Van Middelkoop M, Kuijpers T, et al. A
systematic review on the effectiveness of complementary
and alternative medicine for chronic non-specific low-back
pain. Eur Spine J 2010; 19(8): 1213-1228.
726
